ciprofloxacin has been researched along with Hypoglycemia in 12 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Hypoglycemia: A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A search was made on the World Health Organization global adverse drug reaction database (August 15, 2018) using "ciprofloxacin" as the drug substance and "hypoglycemia" as the reaction term." | 3.91 | Ciprofloxacin and risk of hypolycemia in non-diabetic patients. ( Bahran, F; Berhe, A; Hagos, G; Russom, M, 2019) |
| "To determine the risk of hypoglycemia and associated costs in older patients prescribed glipizide or glyburide who fill a prescription for an antimicrobial drug." | 3.80 | Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas. ( Goodwin, JS; Kuo, YF; Lin, YL; Parekh, TM; Raji, M; Tan, A, 2014) |
| " The risk of hypoglycemia varied according to the type of fluoroquinolone administered, and was most commonly associated with moxifloxacin." | 3.79 | Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan. ( Chang, CH; Chou, HW; Lai, MS; Lee, JJ; Shau, WY; Wang, JL, 2013) |
| " On the other hand, ciprofloxacin, which is widely used in the treatment of infectious diseases, is known to cause hypoglycemia as a side effect." | 3.74 | [Influence of tacrolimus and ciprofloxacin on glucose metabolism]. ( Arai, S; Gouhara, T; Kihira, K; Kitaura, T; Miyake, K; Morita, S; Nagafuji, T; Sato, E; Tayama, Y, 2007) |
| "Population-based data are needed to inform the safe prescribing of fluoroquinolone antibiotics to patients with advanced chronic kidney disease (CKD)." | 1.72 | Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease. ( Ahmadi, F; Garg, AX; Kim, RB; Knoll, GA; Muanda, FT; Silverman, MS; Sontrop, JM; Sood, MM; Weir, MA; Yoo, E, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Muanda, FT | 1 |
| Sood, MM | 1 |
| Weir, MA | 1 |
| Sontrop, JM | 1 |
| Ahmadi, F | 1 |
| Yoo, E | 1 |
| Kim, RB | 1 |
| Silverman, MS | 1 |
| Knoll, GA | 1 |
| Garg, AX | 1 |
| Berhe, A | 1 |
| Russom, M | 1 |
| Bahran, F | 1 |
| Hagos, G | 1 |
| Chou, HW | 1 |
| Wang, JL | 1 |
| Chang, CH | 1 |
| Lee, JJ | 1 |
| Shau, WY | 1 |
| Lai, MS | 1 |
| Parekh, TM | 1 |
| Raji, M | 1 |
| Lin, YL | 1 |
| Tan, A | 1 |
| Kuo, YF | 1 |
| Goodwin, JS | 1 |
| Kelesidis, T | 1 |
| Canseco, E | 1 |
| Vinh, H | 1 |
| Anh, VT | 1 |
| Anh, ND | 1 |
| Campbell, JI | 1 |
| Hoang, NV | 1 |
| Nga, TV | 1 |
| Nhu, NT | 1 |
| Minh, PV | 1 |
| Thuy, CT | 1 |
| Duy, PT | 1 |
| Phuong, le T | 1 |
| Loan, HT | 1 |
| Chinh, MT | 1 |
| Thao, NT | 1 |
| Tham, NT | 1 |
| Mong, BL | 1 |
| Bay, PV | 1 |
| Day, JN | 1 |
| Dolecek, C | 1 |
| Lan, NP | 1 |
| Diep, TS | 1 |
| Farrar, JJ | 1 |
| Chau, NV | 1 |
| Wolbers, M | 1 |
| Baker, S | 1 |
| Lin, G | 1 |
| Hays, DP | 1 |
| Spillane, L | 1 |
| Roberge, R | 1 |
| Mohr, JF | 1 |
| McKinnon, PS | 1 |
| Peymann, PJ | 1 |
| Kenton, I | 1 |
| Septimus, E | 1 |
| Okhuysen, PC | 1 |
| Catero, M | 1 |
| Tayama, Y | 1 |
| Miyake, K | 1 |
| Nagafuji, T | 1 |
| Gouhara, T | 1 |
| Morita, S | 1 |
| Arai, S | 1 |
| Sato, E | 1 |
| Kitaura, T | 1 |
| Kihira, K | 1 |
| Roberge, RJ | 1 |
| Kaplan, R | 1 |
| Frank, R | 1 |
| Fore, C | 1 |
1 review available for ciprofloxacin and Hypoglycemia
| Article | Year |
|---|---|
Dysglycemia and fluoroquinolones: are you putting patients at risk?
Topics: Adolescent; Adult; Aza Compounds; Bacterial Infections; Blood Glucose; Ciprofloxacin; Dose-Response | 2007 |
1 trial available for ciprofloxacin and Hypoglycemia
| Article | Year |
|---|---|
A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Dysentery, Bacillary; Feces; Female; Fluoroq | 2011 |
10 other studies available for ciprofloxacin and Hypoglycemia
| Article | Year |
|---|---|
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Death, Sudden, Cardia | 2022 |
Ciprofloxacin and risk of hypolycemia in non-diabetic patients.
Topics: Adult; Blood Glucose; Ciprofloxacin; Humans; Hypoglycemia; Male; Urinary Tract Infections | 2019 |
Risk of severe dysglycemia among diabetic patients receiving levofloxacin, ciprofloxacin, or moxifloxacin in Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cohort Studies; Diabet | 2013 |
Hypoglycemia after antimicrobial drug prescription for older patients using sulfonylureas.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Dr | 2014 |
Quinolone-induced hypoglycemia: a life-threatening but potentially reversible side effect.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Female; Gastrointestinal Agen | 2010 |
Refractory hypoglycemia from ciprofloxacin and glyburide interaction.
Topics: Aged; Anti-Infective Agents; Blood Glucose; Ciprofloxacin; Diabetes Mellitus, Type 2; Diet; Drug Int | 2004 |
Comment on "refractory hypoglycemia from ciprofloxacin and glyburide interaction".
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relati | 2005 |
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood Glucose; Ceftriaxone; Ciprofloxacin; Fe | 2005 |
[Influence of tacrolimus and ciprofloxacin on glucose metabolism].
Topics: Animals; Anti-Infective Agents; Body Weight; Cell Survival; Cells, Cultured; Ciprofloxacin; Cricetin | 2007 |
Glyburide-ciprofloxacin interaction with resistant hypoglycemia.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Diabetic N | 2000 |